CLNN

SEC source: 0001014108-24-000049 · form4.xml · derivative · entry 2

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Symbiosis II, LLC

Disclosed balance after: 424,358

Underlying: Common Stock · 424,358 shares

Expires not disclosed

F1 · price: The reported securities are included within 424,358 units purchased by the reporting person for $4.712 per Unit. Each Unit consists of one prefunded warrant exercisable at $4.712 and one warrant exercisable at $4.82.

F2 · derivative.expiration_date: There is no expiration date on this prefunded warrant.

SEC source: 0001014108-24-000049 · form4.xml · derivative · entry 1

Ugwumba Chidozie · CIK 0001835544 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Symbiosis II, LLC

Disclosed balance after: 424,358

Underlying: Common Stock · 424,358 shares

Expires 2029-10-01

F1 · price: The reported securities are included within 424,358 units purchased by the reporting person for $4.712 per Unit. Each Unit consists of one prefunded warrant exercisable at $4.712 and one warrant exercisable at $4.82.

SEC source: 0001562180-24-006356 · primarydocument.xml · derivative · entry 1

Mortenson Mark · CIK 0001835427 · Chief Science Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-08-15

F1 · derivative.exercise_date: This option was granted on August 16, 2024 as an option for 25,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.15 per share. The options vest with respect to 1/12th of such shares on September 16, 2024 and then an additional 1/12th of such options vest on the 16th day of each calendar month thereafter until such shares are fully vested.

SEC source: 0001562180-24-006353 · primarydocument.xml · derivative · entry 1

BROWN MORGAN R · CIK 0001266062 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-08-15

F1 · derivative.exercise_date: This option was granted on August 16, 2024 as an option for 10,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.15 per share. The options vest with respect to 1/12th of such shares on September 16, 2024 and then an additional 1/12th of such options vest on the 16th day of each calendar month thereafter until such shares are fully vested.

SEC source: 0001562180-24-006354 · primarydocument.xml · derivative · entry 1

Etherington Robert Dee · CIK 0001835330 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-08-15

F1 · derivative.exercise_date: This option was granted on August 16, 2024 as an option for 25,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.15 per share. The options vest with respect to 1/12th of such shares on September 16, 2024 and then an additional 1/12th of such options vest on the 16th day of each calendar month thereafter until such shares are fully vested.

SEC source: 0001562180-24-005867 · primarydocument.xml · derivative · entry 4

Etherington Robert Dee · CIK 0001835330 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,319

Underlying: Common Stock · 27,320 shares

Expires 2024-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's stock option grant of 1,092,777 options to purchase common stock being reduced to 54,639 options. The exercise option price for these options was increased from $0.15 per share to $3.00 per share.

F6 · shares: On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's stock option grant of 1,092,777 options to purchase common stock being reduced to 54,639 options. The exercise option price for these options was increased from $0.15 per share to $3.00 per share.

SEC source: 0001562180-24-005867 · primarydocument.xml · nonDerivative · entry 1

Etherington Robert Dee · CIK 0001835330 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,149

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's ownership in the previously disclosed 56,593 shares of common stock being reduced to 2,829 shares.

SEC source: 0001562180-24-004890 · primarydocument.xml · derivative · entry 1

Kiernan Matthew · CIK 0001993183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,704

Underlying: Common Stock · 33,704 shares

Expires 2034-06-06

F1 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 33,704 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest immediately upon grant.

SEC source: 0001562180-24-004911 · primarydocument.xml · derivative · entry 1

McLaughlin Vallerie · CIK 0001876030 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,074

Underlying: Common Stock · 37,074 shares

Expires 2034-06-06

F1 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 37,074 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest immediately upon grant.

SEC source: 0001562180-24-004885 · primarydocument.xml · derivative · entry 1

Gay Jonathon · CIK 0001835422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,394

Underlying: Common Stock · 43,394 shares

Expires 2034-06-06

F1 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 43,394 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest immediately upon grant.

SEC source: 0001562180-24-004899 · primarydocument.xml · derivative · entry 2

Mortenson Mark · CIK 0001835427 · Chief Science Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2034-06-06

F2 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 800,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest with respect to the first 25% of such shares on June 7, 2025 and then in 36 equal installments of Common Stock on the 7th day of each calendar month, beginning July 7, 2025, until such shares are fully vested

SEC source: 0001562180-24-004899 · primarydocument.xml · derivative · entry 1

Mortenson Mark · CIK 0001835427 · Chief Science Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000,000

Underlying: Common Stock · 2,000,000 shares

Expires 2034-06-06

F1 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 2,000,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest with respect to the first 33.3% of such shares if Clene Inc. has an NDA accepted by the FDA, an additional 33.3% of such shares if Clene Inc. has an NDA approved by the FDA, and the remaining 33.4% of such shares if Clene Inc. achieves $100,000,000 in revenues in connection with the sales of any approved drugs.

SEC source: 0001562180-24-004886 · primarydocument.xml · derivative · entry 1

WILCOX REED N · CIK 0001266609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,704

Underlying: Common Stock · 33,704 shares

Expires 2034-06-06

F1 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 33,704 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest immediately upon grant.

SEC source: 0001562180-24-004903 · primarydocument.xml · derivative · entry 1

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,723

Underlying: Common Stock · 65,723 shares

Expires 2034-06-06

F1 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 65,723 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest immediately upon grant.

SEC source: 0001562180-24-004908 · primarydocument.xml · derivative · entry 1

Jacobovitz Shalom · CIK 0001835556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,135

Underlying: Common Stock · 50,135 shares

Expires 2034-06-06

F1 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 50,135 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest immediately upon grant.

SEC source: 0001562180-24-004902 · primarydocument.xml · derivative · entry 1

Desai Arjun JJ · CIK 0001982985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,760

Underlying: Common Stock · 38,760 shares

Expires 2034-06-06

F1 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 38,760 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest immediately upon grant.

SEC source: 0001562180-24-004889 · primarydocument.xml · derivative · entry 1

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,399

Underlying: Common Stock · 51,399 shares

Expires 2034-06-06

F1 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 51,399 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest immediately upon grant.

SEC source: 0001562180-24-004897 · primarydocument.xml · derivative · entry 2

Etherington Robert Dee · CIK 0001835330 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,250,000

Underlying: Common Stock · 2,250,000 shares

Expires 2034-06-06

F2 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 2,250,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest with respect to the first 33.3% of such shares if Clene Inc. has an NDA accepted by the FDA, an additional 33.3% of such shares if Clene Inc. has an NDA approved by the FDA, and the remaining 33.4% of such shares if Clene Inc. achieves $100,000,000 in revenues in connection with the sales of any approved drugs.

SEC source: 0001562180-24-004897 · primarydocument.xml · derivative · entry 1

Etherington Robert Dee · CIK 0001835330 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900,000

Underlying: Common Stock · 900,000 shares

Expires 2034-06-06

F1 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 900,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest with respect to the first 25% of such shares on June 7, 2025 and then in 36 equal installments of Common Stock on the 7th day of each calendar month, beginning July 7, 2025, until such shares are fully vested

SEC source: 0001562180-24-004945 · primarydocument.xml · derivative · entry 2

BROWN MORGAN R · CIK 0001266062 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 600,000 shares

Expires 2034-06-06

F2 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 600,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest with respect to the first 33.3% of such shares if Clene Inc. has an NDA accepted by the FDA, an additional 33.3% of such shares if Clene Inc. has an NDA approved by the FDA, and the remaining 33.4% of such shares if Clene Inc. achieves $100,000,000 in revenues in connection with the sales of any approved drugs.

SEC source: 0001562180-24-004945 · primarydocument.xml · derivative · entry 1

BROWN MORGAN R · CIK 0001266062 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2034-06-06

F1 · derivative.exercise_date: This option was granted on June 7, 2024 as an option for 400,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest with respect to the first 25% of such shares on June 7, 2025 and then in 36 equal installments of Common Stock on the 7th day of each calendar month, beginning July 7, 2025, until such shares are fully vested

SEC source: 0001562180-24-004530 · primarydocument.xml · derivative · entry 1

Kiernan Matthew · CIK 0001993183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-05-28

F1 · derivative.exercise_date: This option was granted on May 29, 2024 as an option for 30,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest in 12 equal installments of Common Stock on the 29th day of each calendar month, beginning June 29, 2024, until such shares are fully vested.

SEC source: 0001562180-24-004537 · primarydocument.xml · derivative · entry 1

McLaughlin Vallerie · CIK 0001876030 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-05-28

F1 · derivative.exercise_date: This option was granted on May 29, 2024 as an option for 30,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest in 12 equal installments of Common Stock on the 29th day of each calendar month, beginning June 29, 2024, until such shares are fully vested.

SEC source: 0001562180-24-004535 · primarydocument.xml · derivative · entry 1

Gay Jonathon · CIK 0001835422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-05-28

F1 · derivative.exercise_date: This option was granted on May 29, 2024 as an option for 30,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest in 12 equal installments of Common Stock on the 29th day of each calendar month, beginning June 29, 2024, until such shares are fully vested.

SEC source: 0001562180-24-004531 · primarydocument.xml · derivative · entry 1

WILCOX REED N · CIK 0001266609 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-05-28

F1 · derivative.exercise_date: This option was granted on May 29, 2024 as an option for 30,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest in 12 equal installments of Common Stock on the 29th day of each calendar month, beginning June 29, 2024, until such shares are fully vested.

SEC source: 0001562180-24-004534 · primarydocument.xml · derivative · entry 1

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-05-28

F1 · derivative.exercise_date: This option was granted on May 29, 2024 as an option for 30,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest in 12 equal installments of Common Stock on the 29th day of each calendar month, beginning June 29, 2024, until such shares are fully vested.

SEC source: 0001562180-24-004538 · primarydocument.xml · derivative · entry 1

Jacobovitz Shalom · CIK 0001835556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-05-28

F1 · derivative.exercise_date: This option was granted on May 29, 2024 as an option for 30,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest in 12 equal installments of Common Stock on the 29th day of each calendar month, beginning June 29, 2024, until such shares are fully vested.

SEC source: 0001562180-24-004536 · primarydocument.xml · derivative · entry 1

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-05-28

F1 · derivative.exercise_date: This option was granted on May 29, 2024 as an option for 30,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest in 12 equal installments of Common Stock on the 29th day of each calendar month, beginning June 29, 2024, until such shares are fully vested.

SEC source: 0001562180-24-004533 · primarydocument.xml · derivative · entry 1

Desai Arjun JJ · CIK 0001982985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-05-28

F1 · derivative.exercise_date: This option was granted on May 29, 2024 as an option for 30,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest in 12 equal installments of Common Stock on the 29th day of each calendar month, beginning June 29, 2024, until such shares are fully vested.

SEC source: 0001493152-24-018187 · ownership.xml · nonDerivative · entry 2

General Resonance LLC · CIK 0001308627 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,313,712

SEC source: 0001493152-24-018187 · ownership.xml · nonDerivative · entry 1

General Resonance LLC · CIK 0001308627 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,326,712

SEC source: 0001493152-24-017451 · ownership.xml · nonDerivative · entry 1

General Resonance LLC · CIK 0001308627 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,349,712

SEC source: 0001493152-24-014756 · ownership.xml · nonDerivative · entry 3

General Resonance LLC · CIK 0001308627 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,428,212

SEC source: 0001493152-24-014756 · ownership.xml · nonDerivative · entry 2

General Resonance LLC · CIK 0001308627 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,435,712

SEC source: 0001493152-24-014756 · ownership.xml · nonDerivative · entry 1

General Resonance LLC · CIK 0001308627 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,443,212

SEC source: 0001562180-24-002595 · primarydocument.xml · derivative · entry 1

Kiernan Matthew · CIK 0001993183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,481

Underlying: Common Stock · 29,481 shares

Expires 2034-03-11

F1 · derivative.exercise_date: This option was granted on March 11, 2024 as an option for 29,481 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.44 per share. The options vest immediately upon grant.

SEC source: 0001562180-24-002593 · primarydocument.xml · derivative · entry 1

McLaughlin Vallerie · CIK 0001876030 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,429

Underlying: Common Stock · 32,429 shares

Expires 2034-03-11

F1 · derivative.exercise_date: This option was granted on March 11, 2024 as an option for 32,429 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.44 per share. The options vest immediately upon grant.

SEC source: 0001562180-24-002588 · primarydocument.xml · derivative · entry 1

Gay Jonathon · CIK 0001835422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,957

Underlying: Common Stock · 37,957 shares

Expires 2034-03-11

F1 · derivative.exercise_date: This option was granted on March 11, 2024 as an option for 37,957 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.44 per share. The options vest immediately upon grant.

SEC source: 0001562180-24-002594 · primarydocument.xml · derivative · entry 1

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,488

Underlying: Common Stock · 57,488 shares

Expires 2034-03-11

F1 · derivative.exercise_date: This option was granted on March 11, 2024 as an option for 57,488 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.44 per share. The options vest immediately upon grant.

SEC source: 0001562180-24-002592 · primarydocument.xml · derivative · entry 1

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,959

Underlying: Common Stock · 44,959 shares

Expires 2034-03-11

F1 · derivative.exercise_date: This option was granted on March 11, 2024 as an option for 44,959 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.44 per share. The options vest immediately upon grant.

SEC source: 0001562180-24-002590 · primarydocument.xml · derivative · entry 1

Desai Arjun JJ · CIK 0001982985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,903

Underlying: Common Stock · 33,903 shares

Expires 2034-03-11

F1 · derivative.exercise_date: This option was granted on March 11, 2024 as an option for 33,903 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.44 per share. The options vest immediately upon grant.

SEC source: 0001562180-24-002589 · primarydocument.xml · derivative · entry 1

Jacobovitz Shalom · CIK 0001835556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,853

Underlying: Common Stock · 43,853 shares

Expires 2034-03-11

F1 · derivative.exercise_date: This option was granted on March 11, 2024 as an option for 43,853 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.44 per share. The options vest immediately upon grant.

SEC source: 0001562180-23-007967 · primarydocument.xml · derivative · entry 1

Kiernan Matthew · CIK 0001993183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,730

Underlying: Common Stock · 28,730 shares

Expires 2033-11-28

F1 · derivative.exercise_date: This option was granted on November 28, 2023 as an option for 28,730 shares of Common Stock under the Clene Inc. 2020 Amended Stock Plan at an exercise price of $0.45 per share. The options vest immediately upon grant.

SEC source: 0001562180-23-007965 · primarydocument.xml · derivative · entry 1

McLaughlin Vallerie · CIK 0001876030 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,603

Underlying: Common Stock · 31,603 shares

Expires 2033-11-28

F1 · derivative.exercise_date: This option was granted on November 28, 2023 as an option for 31,603 shares of Common Stock under the Clene Inc. 2020 Amended Stock Plan at an exercise price of $0.45 per share. The options vest immediately upon grant.

SEC source: 0001562180-23-007964 · primarydocument.xml · derivative · entry 1

Gay Jonathon · CIK 0001835422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,990

Underlying: Common Stock · 36,990 shares

Expires 2033-11-28

F1 · derivative.exercise_date: This option was granted on November 28, 2023 as an option for 36,990 shares of Common Stock under the Clene Inc. 2020 Amended Stock Plan at an exercise price of $0.45 per share. The options vest immediately upon grant.

SEC source: 0001562180-23-007968 · primarydocument.xml · derivative · entry 1

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,024

Underlying: Common Stock · 56,024 shares

Expires 2033-11-28

F1 · derivative.exercise_date: This option was granted on November 28, 2023 as an option for 56,024 shares of Common Stock under the Clene Inc. 2020 Amended Stock Plan at an exercise price of $0.45 per share. The options vest immediately upon grant.

SEC source: 0001562180-23-007970 · primarydocument.xml · derivative · entry 1

Desai Arjun JJ · CIK 0001982985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,040

Underlying: Common Stock · 33,040 shares

Expires 2033-11-28

F1 · derivative.exercise_date: This option was granted on November 28, 2023 as an option for 33,040 shares of Common Stock under the Clene Inc. 2020 Amended Stock Plan at an exercise price of $0.45 per share. The options vest immediately upon grant.

SEC source: 0001562180-23-007969 · primarydocument.xml · derivative · entry 1

Jacobovitz Shalom · CIK 0001835556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,736

Underlying: Common Stock · 42,736 shares

Expires 2033-11-28

F1 · derivative.exercise_date: This option was granted on November 28, 2023 as an option for 42,736 shares of Common Stock under the Clene Inc. 2020 Amended Stock Plan at an exercise price of $0.45 per share. The options vest immediately upon grant.

SEC source: 0001562180-23-007966 · primarydocument.xml · derivative · entry 1

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,814

Underlying: Common Stock · 43,814 shares

Expires 2033-11-28

F1 · derivative.exercise_date: This option was granted on November 28, 2023 as an option for 43,814 shares of Common Stock under the Clene Inc. 2020 Amended Stock Plan at an exercise price of $0.45 per share. The options vest immediately upon grant.

SEC source: 0001562180-23-007625 · primarydocument.xml · nonDerivative · entry 1

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,043,686

F1 · price: Mr. Matlin purchased 250,002 shares of common stock of Clene Inc. on November 10, 2023 at prices ranging from $0.39 to $0.42, inclusive, for a weighted average price of $0.40.